Fasting Glycemia Screening Is Alternative to 75-g GTT for GDM

This article originally appeared here.
Share this content:
Fasting Glycemia Screening Is Alternative to 75-g GTT for GDM
Fasting Glycemia Screening Is Alternative to 75-g GTT for GDM

MONDAY, Feb. 1, 2016 (HealthDay News) -- Screening for gestational diabetes with fasting glycemia seems to be an acceptable alternative to universal screening with the complete 75-gram glucose tolerance test, according to a study published online Jan. 25 in BJOG: An International Journal of Obstetrics & Gynaecology.

J. Ryser Rüetschi, from the University Hospitals of Geneva, and colleagues collected 2,298 complete 75-g glucose tolerance tests from pregnant women at 24 to 28 weeks of gestation. They simulated stopping the test if fasting glycemia was <4.4 or ≥5.1 mmol/L, thereby avoiding glucose loading and further glycemia.

The researchers found that within the population, the prevalence of gestational diabetes was 10.9 percent. Among 251 women with gestational diabetes, fasting glycemia was ≥5.1, between 4.4 and <5.1, and <4.4 mmol/L in 47.4, 31.1, and 21.5 percent, respectively. The sensitivity was 78.5 percent with performance of the complete test only in women with fasting glycemia between 4.4 and <5.1 mmol/L; this would avert glucose loading in 63.8 percent of women.

"Screening with fasting glycemia is an attractive alternative to universal screening with the complete 75-g glucose tolerance test," the authors write. "This strategy is, however, slightly less sensitive than previously reported in higher-risk populations."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »